The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC)

Survivin: a unique target for tumor therapy

(2016) Himani Garg et al.   Cancer Cell International

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer

(2016) Karin Birkenkamp-Demtröder et al.   EUROPEAN UROLOGY

A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy

(2016) Armin Soave et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

(2016) C. Alix-Panabieres et al.   Cancer Discovery

Molecular markers in bladder cancer: Novel research frontiers

(2015) Francesca Sanguedolce et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature

(2015) Luis A. Kluth et al.   EUROPEAN UROLOGY

Immunoprofile-based subgrouping of urothelial bladder carcinomas for survival prediction

(2015) Kyungeun Kim et al.   HUMAN PATHOLOGY

Do Circulating Tumor Cells Have a Role in Deciding on Adjuvant Chemotherapy After Radical Cystectomy?

(2015) Armin Soave et al.   Current Urology Reports

Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer

(2014) Paola Gazzaniga et al.   INTERNATIONAL JOURNAL OF CANCER

Survivin as a Preferential Target for Cancer Therapy

(2014) Mahsa Mobahat et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy

(2011) E. De Berardinis et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer

(2010) Angela Gradilone et al.   BJU INTERNATIONAL

Transitional research in bladder cancer: From molecular pathogenesis to useful tissue biomarkers

(2010) Christian Bolenz et al.   CANCER BIOLOGY & THERAPY